Articles with "acute coronary" as a keyword



Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome

Sign Up to like & get
recommendations!
Published in 2018 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2017.4625

Abstract: Importance Physicians need information on how to use the first available high-sensitivity troponin (hsTnT) assay in the United States to identify patients at very low risk for 30-day adverse cardiac events (ACE). Objective To determine… read more here.

Keywords: risk; hstnt; acute coronary; coronary syndrome ... See more keywords

Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial

Sign Up to like & get
recommendations!
Published in 2018 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2018.3408

Abstract: Importance Loading doses of atorvastatin did not show reduction on clinical outcomes in the overall population of patients with acute coronary syndrome (ACS) enrolled in the Statins Evaluation in Coronary Procedures and Revascularization (SECURE-PCI) trial,… read more here.

Keywords: trial; doses atorvastatin; mace; loading doses ... See more keywords
Photo from wikipedia

Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome

Sign Up to like & get
recommendations!
Published in 2021 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2021.22597

Abstract: Key Points Question Is dual antiplatelet therapy with acetylsalicylic acid (ASA) and ticagrelor associated with better clinical outcomes for patients with acute coronary syndrome treated with coronary artery bypass grafting compared with ASA monotherapy? Findings… read more here.

Keywords: ticagrelor; artery bypass; coronary artery; bypass grafting ... See more keywords

Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome

Sign Up to like & get
recommendations!
Published in 2023 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.55709

Abstract: Key Points Question Is short-term oral rivaroxaban a noninferior alternative to parenteral enoxaparin in the acute phase of acute coronary syndrome (ACS)? Findings This equivalence and noninferiority trial including 2046 patients found that short-term rivaroxaban… read more here.

Keywords: coronary syndrome; acute phase; acute coronary; phase acute ... See more keywords

Clinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV

Sign Up to like & get
recommendations!
Published in 2024 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2024.11159

Abstract: This systematic review and meta-analysis investigates clinical outcomes and postdischarge treatment after acute coronary syndromes or revascularization among people living with HIV. read more here.

Keywords: acute coronary; coronary syndromes; revascularization among; clinical outcomes ... See more keywords

COVID-19 Vaccination and Cardiopulmonary Events After Acute Coronary Syndromes

Sign Up to like & get
recommendations!
Published in 2024 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2024.13946

Abstract: This secondary analysis of a randomized clinical trial investigates the association of COVID-19 vaccination with incidence of cardiopulmonary events among patients who had experienced acute coronary syndromes. read more here.

Keywords: cardiopulmonary events; acute coronary; coronary syndromes; vaccination cardiopulmonary ... See more keywords

Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine Care

Sign Up to like & get
recommendations!
Published in 2024 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2024.48389

Abstract: This cohort study compares the cardiovascular and major bleeding outcomes of prasugrel vs ticagrelor among new users undergoing invasive treatment for acute coronary syndrome. read more here.

Keywords: coronary syndrome; prasugrel acute; ticagrelor prasugrel; acute coronary ... See more keywords

Heated Tobacco Product Spread and Hospitalizations for Acute Coronary Syndrome in Japan

Sign Up to like & get
recommendations!
Published in 2025 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2025.37334

Abstract: This cohort study examines trends in the use of heated tobacco products and their association with hospitalizations for acute coronary syndrome among Japanese adults from 2013 to 2022. read more here.

Keywords: acute coronary; coronary syndrome; hospitalizations acute; japan ... See more keywords

Oral antiplatelet agents for the management of acute coronary syndromes: A review for nurses and allied healthcare professionals

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of the American Association of Nurse Practitioners"

DOI: 10.1002/2327-6924.12438

Abstract: Purpose We review the use of oral antiplatelet (OAP) therapies in acute coronary syndrome (ACS) management for nurse practitioners (NPs), focusing on current guideline recommendations. Data sources Treatment guidelines and clinical articles from PubMed. Conclusions… read more here.

Keywords: clopidogrel; ticagrelor; antiplatelet; management ... See more keywords

Stroke and Acute Coronary Syndrome from One Clot

Sign Up to like & get
recommendations!
Published in 2023 at "Annals of Neurology"

DOI: 10.1002/ana.26646

Abstract: A 54-year-old woman, active smoker, presented to the emergency department (ED) because of chest pain and shortness of breath. Both the blood test for myocardial enzymes and the electrocardiogram supported the diagnosis of acute coronary… read more here.

Keywords: coronary syndrome; syndrome one; acute coronary; one clot ... See more keywords

Effectiveness and safety of long‐term therapy with alirocumab in acute coronary syndrome patients: A single‐centre retrospective real‐world study

Sign Up to like & get
recommendations!
Published in 2025 at "British Journal of Clinical Pharmacology"

DOI: 10.1002/bcp.70072

Abstract: Although guidelines recommend in‐hospital initiation of high‐intensity statin therapy in patients with acute coronary syndromes (ACS), low‐density lipoprotein cholesterol (LDL‐C) target levels are frequently not attained. Alirocumab has been demonstrated to be a fast‐acting and… read more here.

Keywords: therapy; acute coronary; real world; world ... See more keywords